David Cuellar, MD
Urology · Round Rock, TXNPI 1376519330
Payments from drug & device makers
Across 389 payments — averaging $1004.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$287K
- Calyxo, Inc.$49K
- Intuitive Surgical$34K
- Strauss Surgical USA LLC$17K
- Johnson & Johnson$694
- Teleflex LLC$513
- plus $3K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 187 | $286,691 |
| Calyxo, Inc. | 7 | $48,544 |
| Intuitive Surgical | 29 | $34,409 |
| Strauss Surgical USA LLC | 1 | $17,100 |
| Johnson & Johnson(2 entities) | 22 | $694 |
| Teleflex LLC | 8 | $513 |
| AbbVie(2 entities) | 18 | $342 |
| Pfizer | 16 | $267 |
| Astellas Pharma US Inc | 13 | $243 |
| Dendreon Pharmaceuticals LLC | 8 | $226 |
| Ferring Pharmaceuticals Inc. | 7 | $225 |
| Smith+Nephew | 2 | $149 |
| AstraZeneca | 5 | $147 |
| Bayer | 6 | $114 |
| Myovant Sciences Inc. | 5 | $109 |
| Sumitomo Pharma America, Inc. | 5 | $106 |
| Travere Therapeutics, Inc. | 5 | $85 |
| Olympus America Inc. | 2 | $83 |
| Endo Pharmaceuticals Inc. | 6 | $82 |
| BD | 1 | $80 |
| Myriad Genetic Laboratories, Inc. | 3 | $66 |
| Progenics Pharmaceuticals, Inc. | 1 | $65 |
| Merck | 3 | $62 |
| Antares Pharma, Inc. | 3 | $59 |
| Immunitybio, Inc. | 2 | $58 |
| Boston Scientific | 3 | $55 |
| Halozyme Inc | 3 | $53 |
| Urogen Pharma, Inc. | 3 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Clarus Therapeutics Inc. | 2 | $42 |
| Blue Earth Diagnostics | 2 | $34 |
| Tolmar Pharmaceuticals, Inc. | 2 | $30 |
| Accord Healthcare, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $18 |
| Stryker | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Neotract Inc. | 1 | $16 |
| Covidien LP | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$390,942 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Round Rock
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
- Homa PorterDallas$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.